{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:03:49Z","timestamp":1783595029473,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00415-023-11730-1","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:01:41Z","timestamp":1682611301000},"page":"4107-4109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-4263","authenticated-orcid":false,"given":"O.","family":"Kremmyda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Feil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bardins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Strupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"11730_CR1","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.1038\/s41598-021-95255-5","volume":"11","author":"GC Churchill","year":"2021","unstructured":"Churchill GC, Strupp M, Factor C, Bremova-Ertl T, Factor M, Patterson MC, Platt FM, Galione A (2021) Acetylation turns leucine into a drug by membrane transporter switching. Sci Rep 11:15812","journal-title":"Sci Rep"},{"key":"11730_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120891","volume":"10","author":"L Gunther","year":"2015","unstructured":"Gunther L, Beck R, Xiong G, Potschka H, Jahn K, Bartenstein P, Brandt T, Dutia M, Dieterich M, Strupp M, la FC, Zwergal A, (2015) N-acetyl-L-leucine accelerates vestibular compensation after unilateral labyrinthectomy by action in the cerebellum and thalamus. PLoS ONE 10:e0120891","journal-title":"PLoS ONE"},{"key":"11730_CR3","doi-asserted-by":"crossref","unstructured":"Kaya E, Smith DA, Smith C, Boland B, Strupp M, Platt FM (2020) Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease. J Clin Med 9","DOI":"10.3390\/jcm9041050"},{"key":"11730_CR4","doi-asserted-by":"crossref","unstructured":"Kaya E, Smith DA, Smith C, Morris L, Bremova-Ertl T, Cortina-Borja M, Fineran P, Morten KJ, Poulton J, Boland B, Spencer J, Strupp M, Platt FM (2021) Acetyl-leucine slows disease progression in lysosomal storage disorders. Brain Commun 3:fcaa148","DOI":"10.1093\/braincomms\/fcaa148"},{"key":"11730_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199969289.001.0001","volume-title":"The neurology of eye movements","author":"RJ Leigh","year":"2015","unstructured":"Leigh RJ, Zee D (2015) The neurology of eye movements. Oxford University Press, Oxford, New York"},{"key":"11730_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/brain\/awp323","volume":"133","author":"AG Shaikh","year":"2010","unstructured":"Shaikh AG, Hong S, Liao K, Tian J, Solomon D, Zee DS, Leigh RJ, Optican LM (2010) Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity. Brain 133:923\u2013940","journal-title":"Brain"},{"key":"11730_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1749-6632.2011.06118.x","volume":"1233","author":"AG Shaikh","year":"2011","unstructured":"Shaikh AG, Thurtell MJ, Optican LM, Leigh RJ (2011) Pharmacological tests of hypotheses for acquired pendular nystagmus. Ann N Y Acad Sci 1233:320\u2013326","journal-title":"Ann N Y Acad Sci"},{"key":"11730_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00415-009-5309-x","volume":"257","author":"M Starck","year":"2010","unstructured":"Starck M, Albrecht H, Pollmann W, Dieterich M, Straube A (2010) Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J Neurol 257:322\u2013327","journal-title":"J Neurol"},{"key":"11730_CR9","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1212\/WNL.0b013e318219fa9c","volume":"76","author":"C Tilikete","year":"2011","unstructured":"Tilikete C, Jasse L, Pelisson D, Vukusic S, Durand-Dubief F, Urquizar C, Vighetto A (2011) Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology 76:1650\u20131657","journal-title":"Neurology"},{"key":"11730_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.0953-816x.2000.01447.x","volume":"13","author":"N Vibert","year":"2001","unstructured":"Vibert N, Vidal PP (2001) In vitro effects of acetyl-DL-leucine (tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig. Eur J Neurosci 13:735\u2013748","journal-title":"Eur J Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11730-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T13:05:19Z","timestamp":1689253519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11730-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["11730"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11730-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"12 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Strupp is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology and Section Editor of F1000. He has received speaker\u2019s honoraria from Abbott, Auris Medical, Biogen, Eisai, Gr\u00fcnenthal, GSK, Henning Pharma, Interacoustics, J&J, MSD, NeuroUpdate, Otometrics, Pierre-Fabre, TEVA, UCB, and Viatris. He receives support for clinical studies from Decibel, U.S.A., Cure within Reach, U.S.A. and Heel, Germany. He distributes \u201cM-glasses\u201d and \u201cPositional vertigo App\u201d. He acts as a consultant for Abbott, AurisMedical, Heel, IntraBio and Sensorion. He is a\u00a0sharholder, investor and chief medical officer of IntraBio.\u00a0S. Bardins is a shareholder of EyeSeeTec GmbH, manufacturer of the eye-tracking equipment used in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}